CA2444518A1 - Biomaterials comprising a melanocyte stimulating hormone (msh), and method of forming - Google Patents

Biomaterials comprising a melanocyte stimulating hormone (msh), and method of forming Download PDF

Info

Publication number
CA2444518A1
CA2444518A1 CA002444518A CA2444518A CA2444518A1 CA 2444518 A1 CA2444518 A1 CA 2444518A1 CA 002444518 A CA002444518 A CA 002444518A CA 2444518 A CA2444518 A CA 2444518A CA 2444518 A1 CA2444518 A1 CA 2444518A1
Authority
CA
Canada
Prior art keywords
msh
vehicle according
vehicle
receptor ligand
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002444518A
Other languages
English (en)
French (fr)
Inventor
Sheila Macneil
Rob Short
Chris Hunter
John Haycock
Nick Williams
Tony Ryan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Sheffield
CellTran Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0109347A external-priority patent/GB0109347D0/en
Priority claimed from GB0109348A external-priority patent/GB0109348D0/en
Application filed by Individual filed Critical Individual
Publication of CA2444518A1 publication Critical patent/CA2444518A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6425—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a receptor, e.g. CD4, a cell surface antigen, i.e. not a peptide ligand targeting the antigen, or a cell surface determinant, i.e. a part of the surface of a cell
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Materials Engineering (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
CA002444518A 2001-04-17 2002-04-17 Biomaterials comprising a melanocyte stimulating hormone (msh), and method of forming Abandoned CA2444518A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0109347A GB0109347D0 (en) 2001-04-17 2001-04-17 Vehicle
GB0109347.5 2001-04-17
GB0109348.3 2001-04-17
GB0109348A GB0109348D0 (en) 2001-04-17 2001-04-17 Vehicle
PCT/GB2002/001713 WO2002083176A2 (en) 2001-04-17 2002-04-17 Biomaterials comprising a melanocyte stimulating hormone (msh), and method of forming

Publications (1)

Publication Number Publication Date
CA2444518A1 true CA2444518A1 (en) 2002-10-24

Family

ID=26245979

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002444518A Abandoned CA2444518A1 (en) 2001-04-17 2002-04-17 Biomaterials comprising a melanocyte stimulating hormone (msh), and method of forming

Country Status (5)

Country Link
US (1) US20040161443A1 (cg-RX-API-DMAC7.html)
EP (1) EP1381394A2 (cg-RX-API-DMAC7.html)
JP (1) JP2004528089A (cg-RX-API-DMAC7.html)
CA (1) CA2444518A1 (cg-RX-API-DMAC7.html)
WO (1) WO2002083176A2 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090232866A1 (en) * 2003-10-07 2009-09-17 Mariann Pavone-Gyongyosi Oligopeptides as coating material for medical products
US7858108B2 (en) * 2003-10-21 2010-12-28 Richard Nagler Elutable surface coating
JP2006068378A (ja) * 2004-09-03 2006-03-16 Terumo Corp 血管内留置物
GB2448153B (en) * 2007-04-04 2011-12-28 Camstent Ltd Mbe Coated medical devices
GB2498356B (en) 2012-01-11 2016-09-07 Camstent Ltd Calixarene-derived coatings for implantable medical devices
US20140088381A1 (en) * 2012-09-26 2014-03-27 Google Inc. Facilitation of tear sample collection and testing using a contact lens
EP3865132B1 (en) * 2017-04-28 2026-02-11 The Schepens Eye Research Institute, Inc. Methods and compositions for reducing corneal endothelial cell loss

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3502099A1 (de) * 1985-01-23 1986-08-07 Dieter Prof. Dr. Dr. 5883 Kierspe Aderhold Therapeutisches, peptid- und/oder aminosaeurehaltiges mittel
FR2691465B1 (fr) * 1992-05-25 1995-08-11 Pf Medicament Complexes comprenant au moins un peptide derive de l'alpha msh, peptide, microsphere, medicament et composition galenique les comprenant.
FR2735131B1 (fr) * 1995-06-12 1997-08-22 Rech De Pathologie Appliquee S Conjugues d'msh avec un acide gras, leur procede de preparation et leur utilisation a titre de medicament
US6541028B1 (en) * 1997-01-17 2003-04-01 Celadon Science, Llc Methods for promoting healing of corneal resurfacing wounds
US20020037566A1 (en) * 1997-04-16 2002-03-28 Rees Riley S. Cell-coated supports
AR012448A1 (es) * 1997-04-18 2000-10-18 Ipsen Pharma Biotech Composicion en forma de microcapsulas o de implantes que comprende un excipiente biodegradable, polimero o co-polimero, o una mezcla de talesexcipientes, y una sustancia activa o una mezcla de sustancias activas, procedimiento para la preparacion de una sustancia soluble en agua de elevada
GB9914616D0 (en) * 1999-06-23 1999-08-25 Univ Sheffield Attachment surface
WO2002006316A2 (en) * 2000-07-14 2002-01-24 Zycos, Inc. Alpha-msh related compounds and methods of use

Also Published As

Publication number Publication date
WO2002083176A3 (en) 2003-08-14
EP1381394A2 (en) 2004-01-21
WO2002083176A2 (en) 2002-10-24
WO2002083176A8 (en) 2002-11-28
JP2004528089A (ja) 2004-09-16
US20040161443A1 (en) 2004-08-19

Similar Documents

Publication Publication Date Title
EP0449973B1 (en) Polypeptide-polymer conjugates active in wound healing
CA2721507C (en) Methods of generating and using procollagen
EP1181323B1 (en) Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups
AU2003210722B9 (en) Bioactive keratin peptides
Yang et al. Cell-mediated delivery of glucocorticoids from thiol-ene hydrogels
WO2014104981A1 (en) Self-assembled ultrashort peptides hydrogels for wound healing, skin care and cosmetics applications
JPH02191629A (ja) グラフト化ペプチド共重合体
US20050282747A1 (en) Methods and compositions for wound healing
Luong et al. In Situ functionalization of Poly (hydroxyethyl methacrylate) Cryogels with Oligopeptides via β‑Cyclodextrin–Adamantane Complexation for Studying Cell-Instructive Peptide Environment
EP2185575A1 (en) Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair
JP2001503747A (ja) 増殖因子様活性を有するペプチド組成物
Li et al. A multifunctional substance P-conjugated chitosan hydrochloride hydrogel accelerates full-thickness wound healing by enhancing synchronized vascularization, extracellular matrix deposition, and nerve regeneration
Pinese et al. Bioactive peptides grafted silicone dressings: A simple and specific method
CN117247427B (zh) 一种肽类化合物、组合物及其应用
Saklani et al. Laminin mimetic angiogenic and collagen peptide hydrogel for enhance dermal wound healing
US20040161443A1 (en) Vehicle
KR101999283B1 (ko) 이관능성 펩티드
RU2012156861A (ru) Химеры витронектин: фактор роста кератиноцитов
EP0838224A2 (en) Polymer-drug conjugates with an enzyme cleavable linker
US11612663B2 (en) Proteoglycan mimetics for enhanced wound healing, angiogenesis, and vascular repair
JP4338516B2 (ja) 血管新生剤
AU776839B2 (en) Detachment surface
WO2008026634A1 (en) Mesenchymal cell proliferation stimulator and skeletal system biomaterial
AU2002251276A1 (en) Biomaterials comprising a melanocyte stimulating hormone (MSH), and method of forming
Ramshaw et al. Applications of collagen in medical devices

Legal Events

Date Code Title Description
FZDE Discontinued